Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: a new concept for individually optimised treatment

In recent decades, the survival rate of head and neck cancer (HNC) patients has improved significantly due to intensified treatment regimens and an increased incidence of relatively favourable Human Papillomavirus associated oropharyngeal cancer.[1 –5] As patients’ life expectancy is prolonged, the need to prevent treatment related toxicities that affect the quality of life and daily functioning of HNC patients has become increasingly relevant.[6,7]

Source: Radiotherapy and Oncology - February 2, 2021 Category: Radiology Authors: Lisa Van den Bosch, Arjen van der Schaaf, Hans Paul van der Laan, Frank J.P. Hoebers, Oda B. Wijers, Johanna G.M. van den Hoek, Karel G.M. Moons, Johannes B. Reitsma, Roel J.H.M. Steenbakkers, Ewoud Schuit, Johannes A. Langendijk Tags: Original Article Source Type: research